Literature DB >> 6722629

Fluorinated anaesthetic nephrotoxicity: an update.

R I Mazze.   

Abstract

The potential for fluorinated anaesthetic agents to cause nephrotoxicity can be summarized in two figures: Figure 2 illustrates the time course of anaesthetic defluorination following administration of methoxyflurane, enflurane and isoflurane; Figure 5 depicts changes in urinary osmolality in response to ADH administration versus peak serum fluoride levels after anaesthesia. Figure 2 clearly demonstrates that the shapes of the serum inorganic fluoride curves are different after methoxyflurane, enflurane and isoflurane anaesthesia. Despite the fact that inorganic fluoride has a half life in blood of only 90 minutes, peak levels were maintained for three days after administration of methoxyflurane. By contrast, peak fluoride levels after administration of the other two agents were reached shortly after the end of anaesthesia and they declined rapidly in the postanaesthetic period. To account for the prolonged postanaesthetic elevation of fluoride levels, one only must realize that methoxyflurane is approximately ten times more lipid soluble than either enflurane or isoflurane. Thus, methoxyflurane is present in the body for days after its administration has ended and is available for postoperative metabolism to inorganic fluoride. Peak fluoride levels also are considerably higher after methoxyflurane anaesthesia than after administration of the other two agents. That is because, on a molar basis, methoxyflurane is biochemically more unstable than either enflurane or isoflurane and is metabolized more per unit of time. Consequently, the area under the fluoride curve is much greater after methoxyflurane anaesthesia than after either enflurane or isoflurane. It is the area under the curve which probably best correlates with nephrotoxicity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6722629     DOI: 10.1007/BF03007030

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  21 in total

1.  Is enflurane defluorination inducible in man?

Authors:  J R Dooley; R I Mazze; S A Rice; J D Borel
Journal:  Anesthesiology       Date:  1979-03       Impact factor: 7.892

2.  The etiology of methoxyflurane nephrotoxicity.

Authors:  M J Cousins; R I Mazze; J C Kosek; B A Hitt; F V Love
Journal:  J Pharmacol Exp Ther       Date:  1974-09       Impact factor: 4.030

3.  Renal effects and metabolism of isoflurane in man.

Authors:  R I Mazze; M J Cousins; G A Barr
Journal:  Anesthesiology       Date:  1974-06       Impact factor: 7.892

4.  Methoxyflurane nephrotoxicity. A study of dose response in man.

Authors:  M J Cousins; R I Mazze
Journal:  JAMA       Date:  1973-09-24       Impact factor: 56.272

5.  A comparison of the renal effects and metabolism of enflurane and methoxyflurane in Fischer 344 rats.

Authors:  G A Barr; M J Cousins; R I Mazze; B A Hitt; J C Kosek
Journal:  J Pharmacol Exp Ther       Date:  1974-01       Impact factor: 4.030

6.  A comparison of the renal effects of isoflurane and methoxyflurane in Fischer 344 rats.

Authors:  M J Cousins; R I Mazze; G A Barr; J C Kosek
Journal:  Anesthesiology       Date:  1973-06       Impact factor: 7.892

7.  Strain differences in metabolism and susceptibility to the nephrotoxic effects of methoxyflurane in rats.

Authors:  R I Mazze; M J Cousins; J C Kosek
Journal:  J Pharmacol Exp Ther       Date:  1973-02       Impact factor: 4.030

8.  The morphology and pathogenesis of nephrotoxicity following methoxyflurane (penthrane) anesthesia. An experimental model in rats.

Authors:  J C Kosek; R I Mazze; M J Cousins
Journal:  Lab Invest       Date:  1972-12       Impact factor: 5.662

9.  Metabolism and renal effects of enflurane in man.

Authors:  M J Cousins; L R Greenstein; B A Hitt; R I Mazze
Journal:  Anesthesiology       Date:  1976-01       Impact factor: 7.892

10.  Renal effects of enflurane anesthesia in Fischer 344 rats with pre-existing renal insufficiency.

Authors:  T S Sievenpiper; S A Rice; F McClendon; J C Kosek; R I Mazze
Journal:  J Pharmacol Exp Ther       Date:  1979-10       Impact factor: 4.030

View more
  3 in total

Review 1.  Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

Review 2.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 3.  Mediators of Regional Kidney Perfusion during Surgical Pneumo-Peritoneum Creation and the Risk of Acute Kidney Injury-A Review of Basic Physiology.

Authors:  Csaba Kopitkó; László Medve; Tibor Gondos; Karim Magdy Mohamed Soliman; Tibor Fülöp
Journal:  J Clin Med       Date:  2022-05-12       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.